Watch the Webinar
In this second session of our two-part Compliance webinar series, discover how leading pharmacovigilance and drug safety teams are transforming the way they create Periodic Safety Update Reports (PSURs) and other safety documents using compliant, AI-powered content automation – while safeguarding and improving their GxP compliance.
Through deep dives on AI in GxP from Roberto Molettieri of Epiqure, and a software demonstration of Quark Publishing Platform (QPP) from Quark’s SVP Enterprise Products Amit Sood, this webinar showcases how PV teams can solve major pain points and safely utilize AI to accelerate aggregate report generation and optimize validation workflows without risking quality or regulatory alignment.
With Microsoft’s Andrew Warrington delivering the foreword and explaining how Microsoft’s technology stack, including Copilot, powers QPP, this is a compliance and AI webinar not to be missed.
Andrew Warrington – Senior Industry Advisor at Microsoft for Healthcare & Life Sciences
As a senior advisor in Microsoft’s corporate Health and Life Sciences practice, Andrew connects large European pharma customers with Microsoft’s industry capabilities and industry partners. Through this he has contributed to significant deal-making in the areas of Genomics, AI for R&D, and collaborative research. Additionally, he played a key role in defining Microsoft’s strategies for its clinical trials and bioinformatics portfolios of products.
Amit Sood – SVP, Enterprise Products
Amit Sood is vice president of global consulting and services, responsible for presales, technical support, and professional and consulting services. He has been with Quark for more than 20 years, helping major global brands in highly regulated environments like financial services, life sciences/pharma and manufacturing with specialized use cases automate the content lifecycle – from creation, collaboration and publishing to delivery and analysis.
Roberto Molettieri – President of Epiqure France SAS | Head of Tech, GCP & GVP Services
Roberto Molettieri is a pharmacovigilance expert with over 18 years of experience in multinational environments. His expertise covers PV systems, inspection readiness, vendor management, auditing, patient safety data management and electronic systems activities, with a particular focus on regulatory compliance in the context of emerging technologies, including Artificial Intelligence. Since 2022, he has co-founded Epiqure and serves as Head of the GVP, GCP, and Tech Services Business Unit, based in Paris.
